Subject: UVND Provides Clear Picture of Future Plans in Exciting New Interview

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
UVND Provides Clear Picture of Future Plans in Exciting New Interview
Hot Stock to WatchHot Stock to Watch

Company: U-Vend (OTCQB: UNVD)

End of Day:

Price: 0.16

Change (%): - 0.018 (10.11)

Volume: 16,723
UVND Chart

U-Vend Inc. CEO Raymond Meyers Provides Details on Recent Company News in a New Audio Interview at

AUSTIN, Texas, July 16, 2015 (GLOBE NEWSWIRE) -, Inc. (SCV) announced today that a new audio interview with U-Vend, Inc. (OTCQB:UNVD) (the “Company”), a consumer products and technology company that develops, distributes and markets various next-generation self-serve electronic kiosks in a variety of locations including grocery stores, drug stores, mass merchants, malls, and other retail environments across North America, is now available. The interview can be heard at

Raymond Meyers, CEO of U-Vend, Inc., called in to to go over the exciting news that the Company has issued over the past 30 days. In the interview, Mr. Myers gives his personal insights into the additional twenty-four Mini-Melt self-serve kiosks within its Southern California market, and as a result, remains ahead of schedule in its goal of installing a minimum of one hundred new machines in this territory by the end of 2016.

Continue Reading

Top PerformerYesterday's Top Performer

PositiveID Corporation (OTCQB: PSID)

End of Day:

Price: 0.0309

Change (%): + 0.0019 (6.55)

Volume: 5,963,576
PSID Chart

About PositiveID Corporation

PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples.

Company Information Sheet

SmallCapVoice Clients' News

Company: Medical Marijuana Inc. (Pink Sheets: MJNA)

Medical Marijuana, Inc.'s Video Statement on Investment Portfolio's Historic Accomplishments and Supporting the Science Behind Cannabis Legalization

MJNA's Spokesperson, Andrew Hard, Explains MJNA's Portfolio at the Cannabis World Congress in New York

SAN DIEGO, July 15, 2015 (GLOBE NEWSWIRE) - “Honestly, if you and I would have sat here two or three years ago, people would be saying, ‘I would never invest in marijuana stocks,'” states Andrew Hard, CEO of CMW Media and Spokesperson for Medical Marijuana, Inc. (Pink Sheets:MJNA) during an interview by Cannabis Financial Network (CFN). “Literally, we are here at the show today with the International Cannabis Association in the middle of New York City - where I used to work as a journalist for over a decade. People here are asking, ‘HOW can I invest my money into this industry?’ and ‘WHERE should I put it?’ So we are light years away from where we were just a couple years before.

A recent video interview with Stuart W. Titus, PhD and CEO of Medical Marijuana, Inc., has valued the U.S. legal cannabis industry at 2.7 billion dollars and, with full legalization, the projected value is 36.8 billion dollars. With more than half of the U.S. states having some type of cannabis laws on the books, the nation is at a pivotal time in history when one could compare repealing alcohol prohibition to the return of legalized cannabis use.

Continue Reading

Other Small Cap News

Company: CannaVest Corp (OTCQB: CANV)

CannaVest's Strategic Efforts to Mainstream Hemp-Derived CBD Oil Products Prove Successful in the Natural Products Sales Channel

LAS VEGAS, NV--(Marketwired - July 16, 2015) - CannaVest Corp (OTCQB: CANV), a leading manufacturer and distributor of hemp-derived Cannabidiol (CBD) products, has initiated its strategy to penetrate the 35 billion dollars U. S. Natural Products sales channel by partnering with established industry leading brokers, with the strategic objective of educating and offering hemp-derived CBD oil products to the 20,000+ natural health retailers nationwide.

Since initiating its strategy in May 2015, placement of CannaVest's brand of PlusCBD Oil™ products are now available in over 120 independent health food stores in the United States, and growing. "Our mission to mainstream hemp-derived CBD oil products is being achieved," stated Michael Mona, Jr., president and chief executive officer of CannaVest. Mr. Mona continued, "We have contracted with established industry leading brokers covering more than 50% of the U.S. and will soon have over 90% coverage. This experienced and knowledgeable sales force will allow CannaVest to quickly and efficiently expand product placement and sales."

Continue Reading

Company: THC BioMed Intl Ltd. (Pink Sheets: THCBF)

THC BioMed Executes Definitive Agreement

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 16, 2015) - THC BioMed Intl Ltd. ("THC") (CSE:THC) (OTC PINK:THCBF) (FRANKFURT:TFHC) is pleased to announce it has Executed a Definitive agreement, as per the terms of the Binding Letter Agreement announced May 15th 2015, (the "Agreement") with Trans-Medica Ltd. ("Trans-Medica"), to provide consulting services and utilize Trans-Medica's proprietary Vertical Grow System for total consideration to THC of $700,000.

Pursuant to the Agreement, THC will immediately supply consulting services to Trans-Medica to assist Trans-Medica in obtaining its own Producer's License under Canada's Marijuana for Medical Purposes Regulations (the "MMPR").

Continue Reading

Company: Cannabis Science, Inc. (Pink Sheets: CBIS)

Cannabis Science Signs Research & Distribution Agreement for California and Announces Guidance for Its New Product Releases in California and International Cannabinoid Research Operations

COLORADO SPRINGS, CO--(Marketwired - Jul 16, 2015) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine and related consulting, is pleased to announce guidance in regards to its State-by-State initiatives, including its new product releases.

On the forefront are the California new product releases. The Company has signed a research and distribution agreement with Cannabis Science Research Foundation (CSRF). The CSRF will be responsible for the release and distribution of the CBIS products for its initial State-by-State initiatives in California. The CSRF distribution agreement is due to the committed focus CBIS has on its federal drug development program. As a result of this new agreement with CSRF the Cannabis Science Patient Access Center will be moved to the CSRF website as well.

Continue Reading

Market News

By Peter Schacknow: CNBC

Early movers: UNH, GS, EBAY, GRMN, BBT, BX & more

Check out which companies are making headlines before the bell:

UnitedHealth Group - The health insurer reported second quarter profit of $1.64 per share, 6 cents above estimates, with revenue also above forecasts. The company also raised its full-year forecast to reflect additional profit from its soon-to-close acquisition of Catamaran Corp.

Goldman Sachs - Goldman reported quarterly profit of $1.98 per share, a number which was trimmed by $2.77 from litigation expenses. Analysts had expected profit of $3.98 per share. Goldman's revenue did beat estimates, however.

EBay - EBay earned an adjusted 76 cents per share, beating estimates by 4 cents, though revenue was slightly below forecasts. The company also announced an addition of 1 billion dollars to its share buyback program. Separately, EBay is near a deal to sell its enterprise business to a private equity consortium for about 900 million dollars, according to The Wall Street Journal.

Continue Reading

By Alex Rosenberg:

These 8 stocks could see oddly big earnings moves

As the heart of earnings season approaches, some stocks are expected to move a lot more than they have in recent years.

A study by MKM Partners' derivatives strategy team found that eight stocks are expected to see moves on earnings that are far larger than their average historical reactions.

Examining U.S. stocks that report earnings in the next month, have a market capitalization greater than 1 billion dollars and robust options trading, MKM found the companies with the biggest implied reactions on earnings. Within that group, eight stocks stand out, with implied moves far bigger than their average-post earnings move over the past eight quarters.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks